Toripalimab

10 registered clinical trials studyying Toripalimab — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Real-World Study of Toripalimab in Extensive-Stage Small Cell Lung Cancer NCT07308379	Fudan University	—
Recruiting	Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients NCT07086469	Sun Yat-sen University	Phase 2
Recruiting	Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small NCT06719700	Sun Yat-sen University	Phase 2
Unknown	Toripalimab Plus Etoposide and Platinum-based Chemotherapy for Genitourinary Small Cell Carcinoma NCT05760053	Sun Yat-sen University	Phase 2
Unknown	A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status NCT05669092	Zhejiang Cancer Hospital	Phase 3
Terminated	Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT NCT04709380	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Phase 3
Unknown	HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular Carcinama NCT04627363	Sun Yat-sen University	Phase 2
Unknown	Concurrent Chemoradiotherapy With Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma: a Prospec NCT04992988	Cancer Hospital of Guangxi Medical University	Phase 2
Unknown	Toripalimab Combine With Rituximab for Treatment of Relapsed Refractory CD20 Positive Diffuse Large B-cell Lym NCT04425824	Chinese Academy of Medical Sciences	Phase 2
Recruiting	Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 (APICAL-GC) NCT04278222	Shanghai Changzheng Hospital	Phase 2